The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, November 10, 2017
The FDA has expanded the indication for Sprycel tablets to include the treatment of children with Philadelphia chromosome-positive chronic myeloid ...
read more
Wednesday, November 15, 2017
Sangamo announced treatment of the first patient in the clinical trial evaluating SB-913, an investigational in vivo genome editing therapy for people...
read more
Wednesday, November 15, 2017
The MDA announced 13 new research and development grants totaling $3.5 million to accelerate development of treatments for muscular dystrophy, ALS, ...
read more
Thursday, November 16, 2017
Evelo Biosciences announced a collaboration with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and ...
read more
Tuesday, November 21, 2017
The Leukemia & Lymphoma Society has committed an additional $46 million to fund the science at medical institutions around the world.
read more
Monday, November 27, 2017
HitGen announced the company has entered into a drug discovery research collaboration with Boehringer Ingelheim.
read more
Monday, November 27, 2017
Eureka announced the FDA allowance of its IND application and authorization to commence a Phase I clinical trial for ET190L1-ARTEMIS T cells.
read more
Friday, December 01, 2017
Bayer announced an IDMC has recommended to unblind a trial of radium Ra 223 dichloride in combination with abiraterone acetate and prednisone/...
read more
Monday, December 04, 2017
Spruce Biosciences announced the FDA has granted orphan drug designation for SPR001 for the treatment of congenital adrenal hyperplasia.
read more
Thursday, December 07, 2017
MeiraGTx announced the FDA have granted rare pediatric disease designation to AAV2/5-OPTIRPE65 for the treatment of patients with Leber's Congenital ...
read more
Friday, December 08, 2017
Scientists from SRI International and Collaborations Pharmaceuticals led a study that used machine learning methods to identify tilorone ...
read more
Monday, December 11, 2017
Eli Lilly and Company announced the FDA has accepted a BLA to review galcanezumab for the prevention of migraine in adults.
read more
Tuesday, December 12, 2017
Investigator-assessed results showed that patients with R/R CLL achieved significantly prolonged median PFS with VENCLEXTA/VENCLYXTO in combination ...
read more
Wednesday, December 13, 2017
Regeneron and Sanofi announced positive topline results from a pivotal Phase 2 clinical study of cemiplimab in 82 patients with advanced CSCC.
read more
Friday, December 15, 2017
Amgen and LabCentral announced that Kernal Biologics and QurAlis have won the Amgen Golden Ticket at LabCentral.
read more